{
  "meta": {
    "id": "test32",
    "title": "Mid Day Module (Medicine-3) - 2024-12-09",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following conditions causing hypercalcemia is least likely to respond to glucocorticoid therapy?",
      "options": [
        {
          "label": "A",
          "text": "Vitamin D intoxication",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vitamin A intoxication",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sarcoidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Non-small cell lung cancer (NSCLC)",
          "correct": true
        }
      ],
      "correct_answer": "D. Non-small cell lung cancer (NSCLC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Non-small cell lung cancer (NSCLC)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Vitamin D intoxication: Glucocorticoids are a standard treatment for this condition.</li><li>\u2022 Option A. Vitamin D intoxication:</li><li>\u2022 Option B. Vitamin A intoxication: Glucocorticoids are effective in treating hypercalcemia related to vitamin A intoxication.</li><li>\u2022 Option B. Vitamin A intoxication:</li><li>\u2022 Option C. Sarcoidosis: Glucocorticoids are a first-line treatment for hypercalcemia caused by sarcoidosis.</li><li>\u2022 Option C. Sarcoidosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The condition causing hypercalcemia that is least likely to respond to glucocorticoid therapy is non-small cell lung cancer (NSCLC) .</li><li>\u27a4 non-small cell lung cancer (NSCLC)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "01e8d029",
      "audio": ""
    },
    {
      "text": "A patient with breast cancer presents with dehydration and a serum calcium of 17 mg/dL. Which of the following is not a useful therapy?",
      "options": [
        {
          "label": "A",
          "text": "IV Fluids",
          "correct": false
        },
        {
          "label": "B",
          "text": "s.c Denosumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "IV Zoledronic acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "IV Calcitonin",
          "correct": true
        }
      ],
      "correct_answer": "D. IV Calcitonin",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-184606.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-184633.jpg"
      ],
      "explanation": "<p><strong>Ans. D) IV Calcitonin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. IV Fluids: Aggressive hydration with isotonic saline is essential to restore intravascular volume and promote renal calcium excretion.</li><li>\u2022 Option A. IV Fluids:</li><li>\u2022 Option B. s.c Denosumab: Denosumab, a monoclonal antibody targeting RANKL, is a potent inhibitor of osteoclast activity and bone resorption, making it effective in malignancy-associated hypercalcemia.</li><li>\u2022 Option B. s.c Denosumab:</li><li>\u2022 Option C. IV Zoledronic Acid: Zoledronic acid, a bisphosphonate, is another potent inhibitor of bone resorption and is commonly used in the management of hypercalcemia of malignancy.</li><li>\u2022 Option C. IV Zoledronic Acid:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a patient with severe hypercalcemia due to malignancy, IV Calcitonin is not as useful due to its transient effect and development of tachyphylaxis.</li><li>\u27a4 IV Calcitonin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7c0b402a",
      "audio": ""
    },
    {
      "text": "A 65-year-old woman with a history of osteoporosis presents with fatigue, nausea, and polyuria. Labs reveal hypercalcemia, metabolic alkalosis, and elevated creatinine. Which of the following is the most likely cause of her symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Primary hyperparathyroidism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Milk-alkali syndrome",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sarcoidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vitamin D intoxication",
          "correct": false
        }
      ],
      "correct_answer": "B. Milk-alkali syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Milk-alkali syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Primary hyperparathyroidism: While it can cause hypercalcemia, it is not typically associated with metabolic alkalosis and renal impairment.</li><li>\u2022 Option A. Primary hyperparathyroidism:</li><li>\u2022 Option C. Sarcoidosis: Can cause hypercalcemia but is usually associated with granulomatous inflammation and elevated 1,25-dihydroxyvitamin D levels.</li><li>\u2022 Option C. Sarcoidosis:</li><li>\u2022 Option D. Vitamin D intoxication: While it can cause hypercalcemia, it is not usually associated with metabolic alkalosis and renal impairment.</li><li>\u2022 Option D. Vitamin D intoxication:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The most likely cause of hypercalcemia, metabolic alkalosis, and renal impairment in an elderly woman with osteoporosis is milk-alkali syndrome .</li><li>\u27a4 milk-alkali syndrome</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9298ffba",
      "audio": ""
    },
    {
      "text": "A 10-year-old child presents with short stature, round face, obesity, shortened fourth and fifth metacarpals, hypocalcemia, and hyperphosphatemia. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Pseudopseudohypoparathyroidism (PPHP)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pseudohypoparathyroidism type 1A (PHP1A)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pseudohypoparathyroidism type 1B (PHP1B)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pseudohypoparathyroidism type 2 (PHP2)",
          "correct": false
        }
      ],
      "correct_answer": "B. Pseudohypoparathyroidism type 1A (PHP1A)",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-190718.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Pseudohypoparathyroidism type 1A (PHP1A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pseudopseudohypoparathyroidism (PPHP): Individuals with PPHP have AHO features but normal calcium, phosphate, and PTH levels. They do not exhibit hormone resistance.</li><li>\u2022 Option A. Pseudopseudohypoparathyroidism (PPHP):</li><li>\u2022 Option C. Pseudohypoparathyroidism type 1B (PHP1B): While PHP1B also presents with hypocalcemia and hyperphosphatemia, it is less likely to be associated with the full spectrum of AHO features.</li><li>\u2022 Option C. Pseudohypoparathyroidism type 1B (PHP1B):</li><li>\u2022 Option D. Pseudohypoparathyroidism type 2 (PHP2): PHP2 is characterized by hypocalcemia and hyperphosphatemia with normal urinary cAMP response to PTH, but it does not typically present with AHO features.</li><li>\u2022 Option D. Pseudohypoparathyroidism type 2 (PHP2):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The child's presentation with short stature, round face, obesity, shortened fourth and fifth metacarpals, hypocalcemia, and hyperphosphatemia is characteristic of Albright's hereditary osteodystrophy (AHO), which is associated with PHP1A.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b3109751",
      "audio": ""
    },
    {
      "text": "A patient had a hip fracture and was started on a bone protective agent. However, after 3 years of use, the patient lost follow-up and stopped therapy. Within 3 months of stopping treatment, the patient developed a new vertebral fracture. What is the drug that was likely given initially and stopped?",
      "options": [
        {
          "label": "A",
          "text": "Zoledronate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alendronate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Denosumab",
          "correct": true
        },
        {
          "label": "D",
          "text": "Raloxifene",
          "correct": false
        }
      ],
      "correct_answer": "C. Denosumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Denosumab</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Zoledronate and Option B. Alendronate: These are bisphosphonates, which have a longer-lasting effect on bone remodeling than denosumab. While there can be a gradual loss of bone density after discontinuing bisphosphonates, it is not as rapid or dramatic as the rebound effect seen with denosumab.</li><li>\u2022 Option A. Zoledronate and Option B. Alendronate:</li><li>\u2022 Option D. Raloxifene: This is a selective estrogen receptor modulator (SERM) with a milder effect on bone density compared to bisphosphonates and denosumab. Its discontinuation is not typically associated with a rapid increase in fracture risk.</li><li>\u2022 Option D. Raloxifene:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Denosumab is associated with a rapid rebound increase in bone turnover and risk of fractures upon discontinuation, which explains the new vertebral fracture within three months of stopping the drug.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7024e5e5",
      "audio": ""
    },
    {
      "text": "A 65-year-old lady presented with a Colles' fracture. She has diabetes and suffered from an MI 2 years ago and a stroke a year ago. Which of the following drugs would be the most appropriate for her osteoporosis treatment?",
      "options": [
        {
          "label": "A",
          "text": "Strontium ranelate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alendronate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Romosozumab",
          "correct": false
        },
        {
          "label": "D",
          "text": "Raloxifene",
          "correct": false
        }
      ],
      "correct_answer": "B. Alendronate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-192229.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Alendronate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Strontium ranelate: Not available in the US and has a potential risk of cardiovascular events, which would be a concern in this patient with a history of MI and stroke.</li><li>\u2022 Option A. Strontium ranelate:</li><li>\u2022 Option C. Romosozumab: While effective in reducing fractures, it has a higher cost and is usually reserved for patients with severe osteoporosis who have failed other treatments. Its safety profile in patients with cardiovascular disease is not yet fully established.</li><li>\u2022 Option C. Romosozumab:</li><li>\u2022 Option D. Raloxifene: Raloxifene is a SERM that is primarily effective in reducing vertebral fractures and has limited data on preventing non-vertebral fractures like Colles' fractures. Additionally, it carries a risk of thromboembolic events which might be a concern in this patient (but note that Raloxifene does not increase CV risk like HRT).</li><li>\u2022 Option D. Raloxifene:</li><li>\u2022 Fracture reduction data:</li><li>\u2022 Fracture reduction data:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alendronate is effective for reducing the risk of fractures and is generally well-tolerated, making it the most appropriate choice for a patient with a history of cardiovascular events and a Colles' fracture.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a417588a",
      "audio": ""
    },
    {
      "text": "A 52-year-old depressed woman presents with a T-score of -2.8 on DEXA scan and severe hot flashes. She has a past history of hysterectomy 6 years ago. Which of the following would be the most suitable treatment for this patient to prevent fractures?",
      "options": [
        {
          "label": "A",
          "text": "Transdermal estrogen",
          "correct": true
        },
        {
          "label": "B",
          "text": "Equine estrogen with medroxyprogesterone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Raloxifene",
          "correct": false
        },
        {
          "label": "D",
          "text": "Teriparatide",
          "correct": false
        }
      ],
      "correct_answer": "A. Transdermal estrogen",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-192756.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Transdermal estrogen</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Equine estrogen with medroxyprogesterone: While this combination therapy is effective for osteoporosis and hot flashes, it is not necessary for women who have had a hysterectomy as it includes progestin, which is used to protect the endometrium in women with a uterus. Addition of progestin can potentially increase the risk of breast cancer as well.</li><li>\u2022 Option B. Equine estrogen with medroxyprogesterone:</li><li>\u2022 Option C. Raloxifene: Raloxifene is a selective estrogen receptor modulator (SERM) that can be used to prevent osteoporosis. However, it can worsen hot flashes and is not the ideal choice for this patient.</li><li>\u2022 Option C. Raloxifene:</li><li>\u2022 Option D. Teriparatide: Teriparatide is an anabolic agent that stimulates bone formation. While effective for osteoporosis, it does not address menopausal symptoms and is generally reserved for patients with severe osteoporosis who have failed other treatments.</li><li>\u2022 Option D. Teriparatide:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Transdermal estrogen is effective for both osteoporosis and severe hot flashes, and since the patient has had a hysterectomy, she does not need progestin.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e776fca9",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman with acute chest pain for the last 3 hours. Aspirin and clopidogrel was given in the ambulance. ECG is taken in ER and shown below. What is the next step?",
      "options": [
        {
          "label": "A",
          "text": "Reteplase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tirofiban",
          "correct": false
        },
        {
          "label": "C",
          "text": "Enoxaparin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Emergent coronary angiography",
          "correct": false
        }
      ],
      "correct_answer": "C. Enoxaparin",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171044.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Reteplase : This is a thrombolytic agent used in STEMI and not in NSTE-ACS.</li><li>\u2022 Option A. Reteplase</li><li>\u2022 Option B. Tirofiban : GpIIb/IIIa inhibitor used primarily during PCI under special circumstances.</li><li>\u2022 Option B. Tirofiban</li><li>\u2022 Option D. Emergent Coronary angiography : While angiography is crucial to confirm the diagnosis and guide further management, immediate anticoagulation with enoxaparin should be initiated first. In this patient with ST depression (a high risk factor), URGENT coronary angiography is optimal (< 24h) rather than immediate (< 2h).</li><li>\u2022 Option D. Emergent Coronary angiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with suspected NSTE-ACS, early administration of enoxaparin is crucial to prevent further thrombus formation while awaiting coronary angiography.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9fd7b7fd",
      "audio": ""
    },
    {
      "text": "A 57-year-old man with exertional chest pain and a positive stress test undergoes angiography revealing complex multivessel coronary artery disease (CAD) involving the left main. He has a left ventricular ejection fraction (LVEF) of 42%. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Coronary artery bypass grafting (CABG)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Medical therapy without revascularization",
          "correct": false
        },
        {
          "label": "C",
          "text": "Myocardial viability testing",
          "correct": false
        },
        {
          "label": "D",
          "text": "Percutaneous coronary intervention (PCI)",
          "correct": false
        }
      ],
      "correct_answer": "A. Coronary artery bypass grafting (CABG)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Medical therapy : Insufficient for complex CAD and reduced LVEF, carries a higher risk of adverse events.</li><li>\u2022 Option B. Medical therapy</li><li>\u2022 Option C. Viability testing : Not necessary before revascularization in this scenario.</li><li>\u2022 Option C. Viability testing</li><li>\u2022 Option D. PCI : Less favorable than CABG for complex multivessel disease, especially with left main involvement.</li><li>\u2022 Option D. PCI</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients with multivessel coronary artery disease, coronary artery bypass grafting is associated with enhanced survival compared with medical therapy alone.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d47dd165",
      "audio": ""
    },
    {
      "text": "A 57-year-old man with stable angina and aspirin allergy is undergoing lifestyle counseling and antianginal therapy. What is the most appropriate cardioprotective treatment?",
      "options": [
        {
          "label": "A",
          "text": "Clopidogrel",
          "correct": true
        },
        {
          "label": "B",
          "text": "Low-dose aspirin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prasugrel",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ticagrelor",
          "correct": false
        }
      ],
      "correct_answer": "A. Clopidogrel",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Low-dose aspirin : Contraindicated due to aspirin allergy.</li><li>\u2022 Option B. Low-dose aspirin</li><li>\u2022 Option C. Prasugrel and Option D. Ticagrelor : More potent antiplatelet agents, typically used in acute coronary syndrome or after PCI, not as monotherapy for stable angina.</li><li>\u2022 Option C. Prasugrel</li><li>\u2022 Option</li><li>\u2022 D. Ticagrelor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 All patients with stable ischemic heart disease should receive guideline-directed therapies consisting of lifestyle modification, cardioprotective therapy, and antianginal medication. Patients with stable ischemic heart disease should receive antiplatelet therapy (low-dose aspirin or clopidogrel in aspirin-intolerant patients) for secondary prevention of cardiovascular events.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "feece3a5",
      "audio": ""
    },
    {
      "text": "A 60-year-old woman with diabetes mellitus received a drug-eluting stent for non-ST elevation acute coronary syndrome (NSTE-ACS). She was started on dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. What is the recommended minimum duration of her antiplatelet therapy?",
      "options": [
        {
          "label": "A",
          "text": "1 month",
          "correct": false
        },
        {
          "label": "B",
          "text": "3 months",
          "correct": false
        },
        {
          "label": "C",
          "text": "6 months",
          "correct": false
        },
        {
          "label": "D",
          "text": "12 months",
          "correct": true
        }
      ],
      "correct_answer": "D. 12 months",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. 1 month: This duration is too short and would significantly increase the risk of stent thrombosis.</li><li>\u2022 Option A. 1 month:</li><li>\u2022 Option B. 3 months: While some studies suggest shorter durations may be safe in select patients, the standard recommendation for patients with diabetes is 12 months.</li><li>\u2022 Option B. 3 months:</li><li>\u2022 Option C. 6 months: This is the minimum duration for patients without diabetes who have received a drug-eluting stent for ACS.</li><li>\u2022 Option</li><li>\u2022 C. 6 months:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understand the recommended duration of dual antiplatelet therapy in patients with diabetes who have undergone percutaneous coronary intervention (PCI) with drug-eluting stents for acute coronary syndrome.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "84130da6",
      "audio": ""
    },
    {
      "text": "A 69-year-old man with persistent angina despite maximally tolerated antianginal therapy. He has orthostatic hypotension and current BP and PR are 100/60 mm Hg and 54/min respectively. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Addition of clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Addition of isosorbide mononitrate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coronary angiography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Exercise echocardiography",
          "correct": false
        }
      ],
      "correct_answer": "C. Coronary angiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Addition of Clopidogrel : Not indicated for stable angina without recent revascularization.</li><li>\u2022 Option A. Addition of Clopidogrel</li><li>\u2022 Option B. Addition of Isosorbide mononitrate : Adding more antianginal medication may not be helpful if the patient is already on maximally tolerated doses. Addition of nitrate in this patient may worsen orthostatic hypotension.</li><li>\u2022 Option B. Addition of Isosorbide mononitrate</li><li>\u2022 Option D. Exercise echocardiography : May provide prognostic information but doesn't identify lesions for revascularization.</li><li>\u2022 Option D. Exercise echocardiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In the setting of persistent symptoms despite maximally tolerated medical therapy, invasive imaging for revascularization assessment is appropriate to improve symptom status and quality of life.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1049ff63",
      "audio": ""
    },
    {
      "text": "A 75-year-old man with a history of atrial fibrillation, diabetes, and peripheral artery disease presents with acute left leg pain, absent pulses, and cold, mottled skin. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Angiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Apixaban",
          "correct": false
        },
        {
          "label": "C",
          "text": "Unfractionated heparin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Venous duplex ultrasonography",
          "correct": false
        }
      ],
      "correct_answer": "C. Unfractionated heparin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Angiography : Essential for diagnosis and planning revascularization, but anticoagulation should be started first.</li><li>\u2022 Option A. Angiography</li><li>\u2022 Option B. Apixaban : Oral anticoagulant, not appropriate in the acute setting of ALI.</li><li>\u2022 Option B. Apixaban</li><li>\u2022 Option D. Venous duplex ultrasonography : Not indicated for ALI, which is an arterial problem.</li><li>\u2022 Option D. Venous duplex ultrasonography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Treat acute limb ischemia with anticoagulation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9c1e1a5",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with no medical history presents with frequent, bothersome palpitations that subside with exercise and in the nights. ECG is shown. Echo and baseline lab tests including CBC and TFT are normal. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Exercise ECG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Propranolol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Reassurance",
          "correct": false
        }
      ],
      "correct_answer": "C. Propranolol",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-172502.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Amiodarone : Antiarrhythmic drug with potential toxicity, not first-line for simple PVCs.</li><li>\u2022 Option A. Amiodarone</li><li>\u2022 Option B. Exercise ECG : Not helpful for diagnosing PVCs.</li><li>\u2022 Option B. Exercise ECG</li><li>\u2022 Option D. Reassurance : Not sufficient for bothersome symptoms.</li><li>\u2022 Option D. Reassurance</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Beta-blockers are the first-line treatment for symptomatic PVCs in patients without structural heart disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "06d982a1",
      "audio": ""
    },
    {
      "text": "A 65-year-old man presents with recurrent chest pain and elevated troponin. ECG is shown. remains in pain despite aspirin, clopidogrel, heparin, and nitroglycerin. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Echocardiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Eplerenone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oxygen per nasal cannula",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urgent coronary angiography",
          "correct": true
        }
      ],
      "correct_answer": "D. Urgent coronary angiography",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-173300.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Echocardiography : May be helpful, but not the immediate priority.</li><li>\u2022 Option A. Echocardiography</li><li>\u2022 Option B. Eplerenone : Indicated in certain post-MI patients, but not the immediate priority for refractory angina.</li><li>\u2022 Option B. Eplerenone</li><li>\u2022 Option C. Oxygen per nasal cannula : Indicated only if the patient is hypoxic.</li><li>\u2022 Option C. Oxygen per nasal cannula</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Urgent or immediate diagnostic angiography with intent to perform revascularization is indicated in patients with NSTE-ACS who have refractory angina or hemodynamic or electrical instability.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3f5894f",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with type 2 diabetes, hypertension, hyperlipidemia, and aortofemoral bypass surgery 2 years ago has an HbA1c of 7.1%. His current medications are metformin, atenolol, ramipril, amlodipine, aspirin, rivaroxaban, and atorvastatin. Which medication is most appropriate to add for cardiovascular risk reduction?",
      "options": [
        {
          "label": "A",
          "text": "Clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Liraglutide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Niacin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pramlintide",
          "correct": false
        }
      ],
      "correct_answer": "B. Liraglutide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Clopidogrel : Patient is already on rivaroxaban and aspirin. Addition of clopidogrel would not provide any additional benefit and only increase the bleeding risk.</li><li>\u2022 Option A. Clopidogrel</li><li>\u2022 Option C. Niacin : No longer recommended for routine use due to lack of benefit and side effects.</li><li>\u2022 Option C. Niacin</li><li>\u2022 Option D. Pramlintide : Amylin analog used for glycemic control, no proven cardiovascular benefit.</li><li>\u2022 Option D. Pramlintide</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients with type 2 diabetes mellitus, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists are associated with reduced rates of adverse cardiovascular events, including stroke, myocardial infarction, and cardiovascular death, compared with placebo.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8acdc0d1",
      "audio": ""
    },
    {
      "text": "A 59-year-old man with type 2 diabetes and a history of stroke is on aspirin, metformin, olmesartan, and rosuvastatin. His LDL-C is 66 mg/dL, HDL-C is 28 mg/dL and HbA1c is 6.8%. What additional medication should be considered for CV risk reduction?",
      "options": [
        {
          "label": "A",
          "text": "Empagliflozin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ezetimibe",
          "correct": false
        },
        {
          "label": "C",
          "text": "Niacin",
          "correct": false
        },
        {
          "label": "D",
          "text": "No changes in management",
          "correct": false
        }
      ],
      "correct_answer": "A. Empagliflozin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Ezetimibe : Not indicated as LDL cholesterol is already well-controlled.</li><li>\u2022 Option B. Ezetimibe</li><li>\u2022 Option C. Niacin : Can increase HDL but no longer recommended for routine use due to lack of benefit and side effects.</li><li>\u2022 Option C. Niacin</li><li>\u2022 Option D. No changes in management : Inadequate as SGLT2 inhibitors provide additional CV benefit.</li><li>\u2022 Option D. No changes in management</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Consider adding SGLT2 inhibitors to the treatment regimen for patients with type 2 diabetes and established ASCVD to reduce CV risk.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "529899d4",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with CAD and diabetes mellitus experiences worsening angina. He is currently on ramipril, diltiazem, metformin, atorvastatin and isosorbide mononitrate twice daily. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Add amlodipine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decrease lisinopril dosage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reduce isosorbide mononitrate dosage to once daily",
          "correct": true
        },
        {
          "label": "D",
          "text": "Repeat coronary angiography",
          "correct": false
        }
      ],
      "correct_answer": "C. Reduce isosorbide mononitrate dosage to once daily",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adding amlodipine : Not the first-line option when nitrate tolerance is suspected.</li><li>\u2022 Option A. Adding amlodipine</li><li>\u2022 Option B. Decreasing lisinopril : Not indicated as blood pressure is controlled.</li><li>\u2022 Option B. Decreasing lisinopril</li><li>\u2022 Option D. Repeat coronary angiography : Not necessary unless there is a suspicion of new coronary lesions or progression of existing ones.</li><li>\u2022 Option D. Repeat coronary angiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Long-acting nitrates provide a constant level of vasodilation and symptom relief throughout the day, but a nitrate-free interval is required to avoid tolerance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "14538cf3",
      "audio": ""
    },
    {
      "text": "A 56-year-old man presents with inferior STEMI and he is successfully treated with PCI. He has a history of paroxysmal AF and was taking flecainide. He was also started on rivaroxaban, metoprolol, and ramipril post PCI. He is currently asymptomatic and now planned for discharge from the hospital. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Ambulatory ECG monitoring",
          "correct": false
        },
        {
          "label": "B",
          "text": "Discontinue flecainide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Discontinue metoprolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Exercise stress testing",
          "correct": false
        }
      ],
      "correct_answer": "B. Discontinue flecainide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ambulatory ECG monitoring : Helpful for assessing AF burden but doesn't address the contraindication of flecainide.</li><li>\u2022 Option A. Ambulatory ECG monitoring</li><li>\u2022 Option C. Discontinue metoprolol : Not ideal as it's essential for managing ischemic heart disease.</li><li>\u2022 Option C. Discontinue metoprolol</li><li>\u2022 Option D. Exercise stress testing : Not recommended immediately post-MI, especially with existing conduction abnormalities.</li><li>\u2022 Option D. Exercise stress testing</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Class IC antiarrhythmics like flecainide are C/I in patients with ischemic heart disease due to an increased risk of ventricular arrhythmias and death.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a8eafec3",
      "audio": ""
    },
    {
      "text": "A 78-year-old man with a history of hypertension and CAD presents with recurrent atrial flutter. He is on dabigatran, metoprolol, ramipril, aspirin, and atorvastatin. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cardiac catheterization",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cardioversion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Catheter ablation",
          "correct": true
        }
      ],
      "correct_answer": "D. Catheter ablation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Amiodarone : Antiarrhythmic drug with potential for toxicity, not the first-line treatment.</li><li>\u2022 Option A. Amiodarone</li><li>\u2022 Option B. Cardiac catheterization : Not needed for treating atrial flutter at this point.</li><li>\u2022 Option B. Cardiac catheterization</li><li>\u2022 Option C. Cardioversion : May provide temporary relief but is not definitive treatment in this case where the patient is experiencing recurrence.</li><li>\u2022 Option C. Cardioversion</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Catheter ablation is the best treatment for recurrent typical atrial flutter.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3acfdd9f",
      "audio": ""
    },
    {
      "text": "A 75-year-old woman with ischemic cardiomyopathy presents with progressive dyspnea, edema and confusion. Her medications include low-dose aspirin, furosemide, carvedilol, ramipril, digoxin, and spironolactone. Her BP is 84/52 mm Hg, PR is 118/min, RR is 28/min and SpO2 is 95 in room air. Her reports are shown below. ALT - 172 U/L, AST - 163 U/L, S. Creatinine - 2.9 mg/dL , S. K - 4.7 mEq/L, S. Na - 132 mEq/L & S. Digoxin - 0.3 ng/mL. What is the most appropriate initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Increase carvedilol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase digoxin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase lisinopril",
          "correct": false
        },
        {
          "label": "D",
          "text": "Start Noradrenaline",
          "correct": true
        }
      ],
      "correct_answer": "D. Start Noradrenaline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increase carvedilol : Beta-blockers are contraindicated in cardiogenic shock.</li><li>\u2022 Option A. Increase carvedilol</li><li>\u2022 Option B. Increase digoxin : Not effective in cardiogenic shock and potentially harmful with AKI.</li><li>\u2022 Option B. Increase digoxin</li><li>\u2022 Option C. Increase lisinopril : Afterload reduction may be considered later, but inotropic support is the priority in this patient with cardiogenic shock.</li><li>\u2022 Option C. Increase lisinopril</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 In patients with cardiogenic shock, inotropes such as Noradrenaline, dobutamine or milrinone may be considered to improve cardiac function.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "78a82400",
      "audio": ""
    },
    {
      "text": "A 75-year-old asymptomatic woman with CAD, diabetes and hypertension presents with palpitations. ECG shows AF. She is on metoprolol, telmisartan, aspirin, and atorvastatin. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Add clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Add oral anticoagulation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discontinue aspirin and begin oral anticoagulation",
          "correct": true
        },
        {
          "label": "D",
          "text": "No change in therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Discontinue aspirin and begin oral anticoagulation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adding clopidogrel : Not indicated, as the patient has no recent ACS or stent.</li><li>\u2022 Option A. Adding clopidogrel</li><li>\u2022 Option B. Adding oral anticoagulation without discontinuing aspirin : Increases bleeding risk.</li><li>\u2022 Option B. Adding oral anticoagulation without discontinuing aspirin</li><li>\u2022 Option D. No change in therapy : Inadequate as the patient needs anticoagulation for stroke prevention.</li><li>\u2022 Option D. No change in therapy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 For most patients with high-risk atrial fibrillation and stable coronary artery disease, oral anticoagulation therapy without an antiplatelet agent is sufficient for prevention of both acute coronary syndromes and thromboembolism.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d1cf12a",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with diabetes and PAD has a right foot ulcer and feeble pulses. Ankle Brachial Index (ABI) on the right is 1.65. What is the next step?",
      "options": [
        {
          "label": "A",
          "text": "Exercise ankle-brachial index (ABI)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lower extremity CT angiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Toe-brachial index (TBI)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Venous duplex ultrasonography",
          "correct": false
        }
      ],
      "correct_answer": "C. Toe-brachial index (TBI)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Exercise ABI : Not useful when resting ABI is uninterpretable.</li><li>\u2022 Option A. Exercise ABI</li><li>\u2022 Option B. Lower Extremity CT angiography : Helpful for planning revascularization, but TBI is the more appropriate initial test in this scenario.</li><li>\u2022 Option B. Lower Extremity CT angiography</li><li>\u2022 Option D. Venous duplex ultrasonography : Evaluates for venous disease, not arterial.</li><li>\u2022 Option D. Venous duplex ultrasonography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Toe-brachial index (TBI) is useful in diagnosing PAD when ankle-brachial index (ABI) is uninterpretable due to non-compressible vessels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d841d436",
      "audio": ""
    },
    {
      "text": "52-year-old woman complains of chest tightness after walking for 2-3 km and relieved with rest. Her resting ECG is normal. She is known case of hypertension and dyslipidemia and currently taking ramipril and atorvastatin. What is the most appropriate diagnostic test?",
      "options": [
        {
          "label": "A",
          "text": "Adenosine single-photon emission CT",
          "correct": false
        },
        {
          "label": "B",
          "text": "Coronary artery calcium scoring",
          "correct": false
        },
        {
          "label": "C",
          "text": "Exercise electrocardiography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stress echocardiography",
          "correct": false
        }
      ],
      "correct_answer": "C. Exercise electrocardiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adenosine single-photon emission CT : Reserved for patients who cannot exercise or have uninterpretable ECGs.</li><li>\u2022 Option A. Adenosine single-photon emission CT</li><li>\u2022 Option B. Coronary artery calcium scoring : Used for risk stratification in asymptomatic patients especially to know the need for a statin. The patient is already on atorvastatin.</li><li>\u2022 Option B. Coronary artery calcium scoring</li><li>\u2022 Option D. Stress echocardiography : Can be considered if exercise ECG is inconclusive.</li><li>\u2022 Option D. Stress echocardiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Exercise ECG is the first-line test for evaluating suspected CAD in patients with typical angina and a normal resting ECG.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6efe450b",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with ischemic cardiomyopathy (EF 20%) and NYHA class III heart failure is on maximally tolerated doses of ACE inhibitor, furosemide, and empagliflozin. ECG shows LBBB with a QRS duration of 130 ms. What is the most appropriate additional treatment?",
      "options": [
        {
          "label": "A",
          "text": "Add carvedilol",
          "correct": true
        },
        {
          "label": "B",
          "text": "Add ivabradine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Add digoxin",
          "correct": false
        },
        {
          "label": "D",
          "text": "CRT-D",
          "correct": false
        }
      ],
      "correct_answer": "A. Add carvedilol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Add Ivabradine : Indicated only after maximally tolerated beta-blocker dose.</li><li>\u2022 Option B. Add Ivabradine</li><li>\u2022 Option D. CRT-D : Considered if LVEF remains \u226435%, QRS duration \u2265150 ms, and NYHA class II-IV symptoms despite optimal medical therapy.</li><li>\u2022 Option D. CRT-D</li><li>\u2022 Option C. Add digoxin : Considered for primary prevention of sudden cardiac death in patients with LVEF \u226435% despite optimal medical therapy.</li><li>\u2022 Option C.</li><li>\u2022 Add digoxin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Initiate beta-blocker therapy in patients with HFrEF who are not already on it, as part of guideline-directed medical therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5193c110",
      "audio": ""
    },
    {
      "text": "A 64-year-old woman presents with acute type B aortic dissection involving the descending thoracic aorta with a maximal aortic diameter of 6.8 cm. Her BP is 173/99 mm Hg and PR is 90/min. What is the most appropriate initial management?",
      "options": [
        {
          "label": "A",
          "text": "Immediate endovascular stenting",
          "correct": false
        },
        {
          "label": "B",
          "text": "Immediate open surgical repair",
          "correct": false
        },
        {
          "label": "C",
          "text": "IV labetalol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Repeat CT angiography in 12 hours",
          "correct": false
        }
      ],
      "correct_answer": "C. IV labetalol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Immediate endovascular stenting: Endovascular stenting can be used to treat patients with descending aortic aneurysms; however, there is scant evidence to support this as an initial treatment option for aneurysm with dissection. After medical stabilization, thoracic endovascular aortic repair (TEVAR) with stent grafting can be used; typical indications include descending aortic aneurysm diameter greater than 6.0 cm, rapid growth (>0.5 cm/year), or end-organ damage. TEVAR has the advantage over surgical operation of lower morbidity and shorter hospital stay, although there may be complications, including stroke, spinal ischemia, and aortic graft endoleaks. This patient should be treated with stent implantation only after medical stabilization.</li><li>\u2022 Option A. Immediate endovascular stenting:</li><li>\u2022 Option B. Immediate open surgical repair: Open surgical repair of the descending aorta is not recommended in patients with uncomplicated type B aortic dissection because of high rates of morbidity (such as paraplegia) and mortality. This patient has no signs or symptoms of complications that would prompt immediate surgical repair.</li><li>\u2022 Option B. Immediate open surgical repair:</li><li>\u2022 Option D. Repeat CT angiography in 12 hours: Repeat CT angiography at 12 hours is not indicated unless the patient does not stabilize with medical therapy. Serial imaging (usually magnetic resonance angiography) is typically performed in asymptomatic patients at the time of discharge and then periodically in patients who do not have an indication for aneurysmal repair to screen for extension or recurrence of the dissection, aneurysm formation, and leakage.</li><li>\u2022 Option D. Repeat CT angiography in 12 hours:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Patients with uncomplicated type B aortic dissection may be initially treated with medical therapy, including \u03b2-blockers, sodium nitroprusside, and opioids.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7b42022",
      "audio": ""
    },
    {
      "text": "An 81-year-old woman had a drug-eluting stent (DES) for chronic stable angina 1 month ago. She is currently on aspirin and clopidogrel. She is a known case of hypertension, dyslipidaemia, CKD and peptic ulcer disease and was on medications for the same. She wants to minimize DAPT in view of her age and comorbidities. How long should she continue DAPT?",
      "options": [
        {
          "label": "A",
          "text": "Discontinue clopidogrel now",
          "correct": false
        },
        {
          "label": "B",
          "text": "Discontinue clopidogrel in 5 months",
          "correct": true
        },
        {
          "label": "C",
          "text": "Discontinue clopidogrel in 11 months",
          "correct": false
        },
        {
          "label": "D",
          "text": "Discontinue clopidogrel and aspirin in 11 months",
          "correct": false
        }
      ],
      "correct_answer": "B. Discontinue clopidogrel in 5 months",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Discontinuing clopidogrel in 1 month can be done in case of bare metal stents (BMS) and not DES.</li><li>\u2022 Option A.</li><li>\u2022 Option C. 12 months of DAPT is recommended in patient with ACS.</li><li>\u2022 Option C.</li><li>\u2022 Option D . Aspirin should be continued indefinitely in patients with CAD.</li><li>\u2022 Option D</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Dual antiplatelet therapy is recommended for at least 6 months after drug-eluting stent placement for treatment of stable angina.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f947784e",
      "audio": ""
    },
    {
      "text": "A 40-year-old male with recent post-CABG (coronary artery bypass graft) status presents with chest pain. On arrival, his blood pressure is 60/30 mmHg with a heart rate of 30/min. The ECG shows a narrow complex arrhythmia. The patient has already received three boluses of IV atropine. While awaiting transcutaneous pacing, which of the following is the next appropriate step in management?",
      "options": [
        {
          "label": "A",
          "text": "Another bolus of atropine",
          "correct": false
        },
        {
          "label": "B",
          "text": "IV Norepinephrine",
          "correct": false
        },
        {
          "label": "C",
          "text": "IV Dopamine",
          "correct": true
        },
        {
          "label": "D",
          "text": "IV Dobutamine",
          "correct": false
        }
      ],
      "correct_answer": "C. IV Dopamine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Another bolus of atropine: As per ACLS guidelines, a maximum of three boluses of atropine are recommended for symptomatic bradycardia. Further doses are unlikely to be effective.</li><li>\u2022 Option A. Another bolus of atropine:</li><li>\u2022 Option B. IV Norepinephrine: While norepinephrine is a potent vasopressor, it can also worsen bradycardia due to its reflex bradycardia effect (baroreceptor response).</li><li>\u2022 Option B. IV Norepinephrine:</li><li>\u2022 Opion D. IV Dobutamine: Dobutamine primarily acts on beta-1 receptors, increasing heart rate and contractility, but it can also cause vasodilation (beta-2 effects), potentially worsening hypotension.</li><li>\u2022 Opion D. IV Dobutamine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Chronotropic drugs like dopamine can be tried while awaiting pacing in symptomatic bradycardia with hypotension, especially when atropine has been ineffective.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "334e0e3b",
      "audio": ""
    },
    {
      "text": "Which of the following non-invasive tests has the best accuracy in detecting coronary stenosis?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac magnetic resonance perfusion scan",
          "correct": false
        },
        {
          "label": "B",
          "text": "Coronary CT angiography",
          "correct": true
        },
        {
          "label": "C",
          "text": "SPECT MPI",
          "correct": false
        },
        {
          "label": "D",
          "text": "Exercise echocardiography",
          "correct": false
        }
      ],
      "correct_answer": "B. Coronary CT angiography",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-091702.png"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. CMR perfusion have high sensitivity, but their specificity is not as high as Coronary CTA, meaning they might produce more false-positive results.</li><li>\u2022 Option A. CMR perfusion</li><li>\u2022 Option D. Exercise echocardiography and Option C. SPECT MPI have lower sensitivity and specificity than Coronary CTA, indicating a higher chance of both false negatives and false positives.</li><li>\u2022 Option D. Exercise echocardiography</li><li>\u2022 Option</li><li>\u2022 C. SPECT MPI</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Coronary CTA is a highly accurate non-invasive test for detecting coronary stenosis due to its excellent sensitivity and specificity. It is a valuable tool for diagnosing and evaluating CAD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f67c218",
      "audio": ""
    },
    {
      "text": "A 46-year-old man with bacterial pneumonia experiences a sudden lightheadedness. His BP is stable, and the rhythm strip is shown. Which of the following is most likely to lead to sustained improvement in heart rate?",
      "options": [
        {
          "label": "A",
          "text": "Adenosine 6 mg IV",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carotid body massage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metoprolol 5 mg IV",
          "correct": true
        },
        {
          "label": "D",
          "text": "Valsalva maneuver",
          "correct": false
        }
      ],
      "correct_answer": "C. Metoprolol 5 mg IV",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-182921.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adenosine 6 mg IV : Primarily used for supraventricular tachycardia (SVT) and may not be effective in FAT.</li><li>\u2022 Option A. Adenosine 6 mg IV</li><li>\u2022 Option B. Carotid body massage : A vagal maneuver that may temporarily slow the heart rate but is not a definitive treatment.</li><li>\u2022 Option B. Carotid body massage</li><li>\u2022 Option D. Valsalva maneuver : A vagal maneuver that may temporarily slow the heart rate but is not a definitive treatment.</li><li>\u2022 Option D. Valsalva maneuver</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Focal atrial tachycardia is not dependent on the AV node and beta-blockers or non-dihydropyridine CCBs are the preferred treatment options for rate control.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "adfe0a42",
      "audio": ""
    },
    {
      "text": "You are called to the ER for a young patient in cardiac arrest during exercise. ECG showed bidirectional VT and it was cardioverted immediately. ECG post-cardioversion is normal. 2D Echo and cardiac MRI are also normal. Mutations in which protein are responsible for this?",
      "options": [
        {
          "label": "A",
          "text": "Calcium ryanodine receptor",
          "correct": true
        },
        {
          "label": "B",
          "text": "Desmosomal proteins",
          "correct": false
        },
        {
          "label": "C",
          "text": "Potassium channel",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sarcomere proteins",
          "correct": false
        }
      ],
      "correct_answer": "A. Calcium ryanodine receptor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Desmosomal proteins: Mutations in desmosomal proteins cause arrhythmogenic right ventricular cardiomyopathy (ARVC), which is a structural heart disease.</li><li>\u2022 Option B. Desmosomal proteins:</li><li>\u2022 Option C. Potassium channel: Mutations in potassium channels can cause long QT syndrome. In this case resting ECG would have showed long QTc.</li><li>\u2022 Option C. Potassium channel:</li><li>\u2022 Option D. Sarcomere proteins: Mutations in sarcomere proteins cause hypertrophic cardiomyopathy (HCM), which would have resulted in structural heart disease.</li><li>\u2022 Option D. Sarcomere proteins:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognize bidirectional VT as a hallmark of CPVT, an inherited arrhythmia syndrome caused by mutations in the cardiac ryanodine receptor (RyR2).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5f9fa051",
      "audio": ""
    },
    {
      "text": "You are seeing a 75-year-old man admitted for non-ST-elevation myocardial infarction. He has a history of CAD and takes daily aspirin. He's had multiple angina episodes in the past few days, has ST-segment depression on ECG, and elevated troponin. Which of the following details does NOT confer increased risk of poor outcomes?",
      "options": [
        {
          "label": "A",
          "text": "Two anginal episode in 24 hours.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Age.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Daily aspirin use.",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above confer increased risk.",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above confer increased risk.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Two anginal episode in 24 hours : High risk indicating loss of ischemic preconditioning and an active/ongoing ischemia.</li><li>\u2022 Option A. Two anginal episode in 24 hours</li><li>\u2022 Option B. Age : Advanced age is the SINGLE most important risk factor in ACS.</li><li>\u2022 Option B. Age</li><li>\u2022 Option C. Daily aspirin use : While aspirin is cardioprotective, ACS despite use of aspirin indicates high thrombus burden and hence, high risk.</li><li>\u2022 Option C. Daily aspirin use</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 TIMI score for NSTE-ACS is important!</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "732b13e2",
      "audio": ""
    },
    {
      "text": "A 74-year-old man with a history of smoking presents with progressive bilateral calf pain that worsens with walking and improves with rest. He has normal resting ankle-brachial index (ABI) values. What is the most appropriate next test?",
      "options": [
        {
          "label": "A",
          "text": "Exercise ankle-brachial index (ABI) testing",
          "correct": true
        },
        {
          "label": "B",
          "text": "Invasive angiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Magnetic resonance angiography (MRA)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Segmental lower extremity blood pressure testing",
          "correct": false
        }
      ],
      "correct_answer": "A. Exercise ankle-brachial index (ABI) testing",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Invasive angiography : Not the initial test, reserved for patients with severe PAD or when revascularization is planned.</li><li>\u2022 Option B. Invasive angiography</li><li>\u2022 Option C. MRA : Another option for anatomic imaging, but exercise ABI is a less invasive first step.</li><li>\u2022 Option C. MRA</li><li>\u2022 Option D. Segmental lower extremity blood pressure testing : Used to localize PAD, but not necessary as the initial test when the ABI is normal.</li><li>\u2022 Option D. Segmental lower extremity blood pressure testing</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 25% of patients with typical claudication symptoms have a normal or borderline ankle-brachial index.</li><li>\u27a4 Exercise ABI testing is useful to evaluate for peripheral artery disease in patients with normal ABI values (>0.90 and \u22641.40) and high suspicion of PAD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d56515ae",
      "audio": ""
    },
    {
      "text": "A 74-year-old man with peripheral artery disease (PAD) was prescribed atorvastatin. He has read in a newspaper that statins can cause muscle aches and stopped taking atorvastatin after he developed worsening leg pain upon walking. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Atorvastatin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Colestipol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ezetimibe",
          "correct": false
        },
        {
          "label": "D",
          "text": "Icosapent ethyl",
          "correct": false
        }
      ],
      "correct_answer": "A. Atorvastatin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Colestipol (bile acid resin): Not a first-line agent for PAD.</li><li>\u2022 Option B. Colestipol</li><li>\u2022 Option C. Ezetimibe (cholesterol absorption inhibitor): Monotherapy with ezetimibe is NOT a substitute for statin therapy. Can be used as an add on if LDL-C is not adequately reduced.</li><li>\u2022 Option C. Ezetimibe</li><li>\u2022 Option D. Icosapent ethyl (fish oil): Used for triglyceride lowering, which may be considered in addition to statins to lower CV risk (in patients with triglycerides of 135-499 mg/dL).</li><li>\u2022 Option D. Icosapent ethyl</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Peripheral artery disease is considered a clinical atherosclerotic cardiovascular disease.</li><li>\u27a4 Statin therapy is recommended for secondary prevention of atherosclerotic cardiovascular disease in patients with peripheral artery disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bc62d83f",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman 2 weeks postpartum presents with chest pain, ST-segment elevation in anterior leads, and elevated troponin. She has no risk factors for atherosclerosis. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Atherosclerotic plaque rupture",
          "correct": false
        },
        {
          "label": "B",
          "text": "Peripartum cardiomyopathy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Spontaneous coronary artery dissection (SCAD)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stress-induced (takotsubo) cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Spontaneous coronary artery dissection (SCAD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Atherosclerotic plaque rupture : Unlikely in a young woman with no risk factors.</li><li>\u2022 Option A. Atherosclerotic plaque rupture</li><li>\u2022 Option B. Peripartum cardiomyopathy : Presents with heart failure symptoms and global LV dysfunction, not ST-elevation.</li><li>\u2022 Option B. Peripartum cardiomyopathy</li><li>\u2022 Option D. Takotsubo cardiomyopathy : Typically triggered by stress, often presents with apical ballooning on echo. Common in post-menopausal women (not young women).</li><li>\u2022 Option D. Takotsubo cardiomyopathy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Spontaneous coronary artery dissection is the most common cause of pregnancy-associated myocardial infarction and occurs most commonly in the first month postpartum</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f22c69b6",
      "audio": ""
    },
    {
      "text": "A 73-year-old man presents with a 3-hour history of chest pain. His BP is 80/50 mmHg, HR is 120/min and has elevated JVP and clear lungs. ECG is shown. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Intra-aortic balloon pump placement",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous dobutamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intravenous 0.9% saline",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oral metoprolol",
          "correct": false
        }
      ],
      "correct_answer": "C. Intravenous 0.9% saline",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-101859.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Intra-aortic balloon pump : Indicated in cardiogenic shock with LV dysfunction, but not the first-line treatment for RV infarction.</li><li>\u2022 Option A. Intra-aortic balloon pump</li><li>\u2022 Option B. Intravenous dobutamine: Inotrope may be considered if fluids are ineffective, but not the initial management.</li><li>\u2022 Option B. Intravenous dobutamine:</li><li>\u2022 Option D. Oral metoprolol : Beta-blockers can worsen hypotension and should be avoided in RV infarction.</li><li>\u2022 Option D. Oral metoprolol</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 A patient with an inferior myocardial infarction with right ventricular involvement and hypotension should receive intravenous fluids.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8038430",
      "audio": ""
    },
    {
      "text": "A 74-year-old man with a history of CABG presents with progressive fatigue, dyspnea, elevated jugular venous pressure with Kussmaul's sign, and a pericardial knock. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac tamponade",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic liver disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Constrictive pericarditis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Restrictive cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Constrictive pericarditis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cardiac tamponade : Would not present with Kussmaul's sign or pericardial knock.</li><li>\u2022 Option A. Cardiac tamponade</li><li>\u2022 Option B. Chronic liver disease : Can cause ascites and edema but not the other findings.</li><li>\u2022 Option B. Chronic liver disease</li><li>\u2022 Option D. Restrictive cardiomyopathy : Can mimic constrictive pericarditis, but the history of CABG makes the latter more likely.</li><li>\u2022 Option D. Restrictive cardiomyopathy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Kussmaul sign and pericardial knock, if present, are helpful clues to the presence of constrictive pericarditis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37fb2263",
      "audio": ""
    },
    {
      "text": "A 58-year-old man presents with an chest pain, nausea and diaphoresis. ECG is shown. The nearest tertiary care center is 140 minutes away. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "CT angiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thrombolysis and admission to a telemetry bed",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thrombolysis and transfer to a PCI center",
          "correct": true
        },
        {
          "label": "D",
          "text": "Transfer to a tertiary care center",
          "correct": false
        }
      ],
      "correct_answer": "C. Thrombolysis and transfer to a PCI center",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-102708.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. CT angiography : Delays reperfusion therapy, which is crucial in STEMI.</li><li>\u2022 Option A. CT angiography</li><li>\u2022 Option B. Thrombolyse and admit : Does not allow for timely angiography and potential rescue PCI.</li><li>\u2022 Option B. Thrombolyse and admit</li><li>\u2022 Option D. Transfer to tertiary care center : Delays reperfusion and worsens outcomes.</li><li>\u2022 Option D. Transfer to tertiary care center</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 For patients with STEMI, thrombolytic therapy is recommended if symptom onset is within 12 hours and PPCI is not available within 120 minutes of FMC.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2b83912",
      "audio": ""
    },
    {
      "text": "A 73-year-old woman presents with severe chest pain for the last 3 hours. She is diaphoretic and appears drowsy. Her BP is 80/60 mm Hg and PR is 60/min. ECG is shown below. She was started on aspirin, clopidogrel and heparin. What is the next step?",
      "options": [
        {
          "label": "A",
          "text": "Atropine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tenecteplase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Primary Angioplasty",
          "correct": false
        },
        {
          "label": "D",
          "text": "Temporary pacing",
          "correct": true
        }
      ],
      "correct_answer": "D. Temporary pacing",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-102907.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Atropine: Atropine may be useful for bradycardia but is unlikely to be effective in the setting of high-grade AV block. Additionally, it does not address the underlying myocardial ischemia.</li><li>\u2022 Option A. Atropine:</li><li>\u2022 Option B. Tenecteplase: While fibrinolysis with tenecteplase may be considered in some STEMI cases, it is not the first-line therapy in this case.</li><li>\u2022 Option B. Tenecteplase:</li><li>\u2022 Option C. Primary Angioplasty: Primary PCI is the preferred reperfusion strategy for STEMI, but it should be performed after stabilizing the patient's hemodynamics with temporary pacing.</li><li>\u2022 Option C. Primary Angioplasty:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Anterior MI related bradyarrhythmias are inherently unstable and need temporary pacing.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ea3e1ed",
      "audio": ""
    },
    {
      "text": "A 71-year-old woman presents with cardiogenic shock. ECG showed ST depressions in multiple leads and her Troponins were elevated. PCI was performed successfully but she continues to be in cardiogenic shock and she is on aspirin, prasugrel and norepinephrine. Which of the following is the most appropriate additional management?",
      "options": [
        {
          "label": "A",
          "text": "Digoxin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intra-aortic balloon pump (IABP) placement",
          "correct": true
        },
        {
          "label": "C",
          "text": "Metoprolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urgent cardiac transplantation",
          "correct": false
        }
      ],
      "correct_answer": "B. Intra-aortic balloon pump (IABP) placement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Digoxin : Weak inotrope, unlikely to be effective in cardiogenic shock.</li><li>\u2022 Option A. Digoxin</li><li>\u2022 Option C. Metoprolol : Beta-blocker, contraindicated in cardiogenic shock due to negative inotropic effects.</li><li>\u2022 Option C. Metoprolol</li><li>\u2022 Option D. Urgent cardiac transplantation : Not feasible in the acute setting.</li><li>\u2022 Option D. Urgent cardiac transplantation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 IABP is a mechanical circulatory support device that can temporarily improve hemodynamics in patients with cardiogenic shock after MI by reducing afterload and improving coronary perfusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "75e4b913",
      "audio": ""
    },
    {
      "text": "A 69-year-old woman with a history of NSTEMI and AF underwent a successful PCI with a drug eluting stent. What is the most appropriate management of her antithrombotic therapy?",
      "options": [
        {
          "label": "A",
          "text": "Aspirin plus clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aspirin plus ticagrelor",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aspirin plus rivaroxaban plus ticagrelor",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rivaroxaban plus ticagrelor",
          "correct": true
        }
      ],
      "correct_answer": "D. Rivaroxaban plus ticagrelor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Aspirin plus clopidogrel: This is traditional dual antiplatelet therapy (DAPT) and does not address the need for anticoagulation in AF.</li><li>\u2022 Option A. Aspirin plus clopidogrel:</li><li>\u2022 Option B. Aspirin plus ticagrelor: Similar to option a, it lacks anticoagulation for AF.</li><li>\u2022 Option B. Aspirin plus ticagrelor:</li><li>\u2022 Option C. Aspirin plus rivaroxaban plus ticagrelor: Triple therapy is no longer recommended as it increases bleeding risk without significant additional benefit compared to dual therapy.</li><li>\u2022 Option C. Aspirin plus rivaroxaban plus ticagrelor:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Among patients with atrial fibrillation who have undergone percutaneous coronary intervention for acute coronary syndrome, double therapy with clopidogrel or ticagrelor plus a direct oral anticoagulant is recommended over triple therapy with an oral anticoagulant, aspirin, and P2Y12 inhibitor to reduce the risk for bleeding.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e8e24145",
      "audio": ""
    },
    {
      "text": "A 51-year-old male presents with chest pain, 4 days after he was diagnosed with an ST elevation myocardial infarction (STEMI). It is severe, central chest pain with radiation to the trapezius and worse with deep inspiration. The pain woke him from sleep and has improved slightly after getting up out of bed. His Troponin levels were unchanged and ECG showed new saddle-shaped ST elevations in inferior and lateral leads. What is the likely cause?",
      "options": [
        {
          "label": "A",
          "text": "Recurrent MI",
          "correct": false
        },
        {
          "label": "B",
          "text": "Early Pericarditis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dressler's Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Severe GERD due to aspirin",
          "correct": false
        }
      ],
      "correct_answer": "B. Early Pericarditis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Recurrent MI: While possible, the unchanged troponin and the specific characteristics of the chest pain make it less likely.</li><li>\u2022 Option A. Recurrent MI:</li><li>\u2022 Option C. Dressler's Syndrome: This is a post-MI syndrome occurring weeks to months after the infarction, characterized by fever, pericarditis, pleuritis, and leukocytosis. It is too early for this diagnosis.</li><li>\u2022 Option C. Dressler's Syndrome:</li><li>\u2022 Option D. Severe GERD due to aspirin: GERD can cause chest pain, but the pain is typically burning and not pleuritic. Additionally, the ECG changes are not consistent with GERD.</li><li>\u2022 Option D. Severe GERD due to aspirin:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Early pericarditis is a common complication of STEMI that typically occurs in the first week after MI.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ff3dfb9d",
      "audio": ""
    },
    {
      "text": "A 52-year-old woman experiences shortness of breath after a recent MI that was treated with a drug-eluting stent. Her current medications are aspirin, ticagrelor, enalapril, metoprolol, and atorvastatin. Her physical examination, chest X-ray, and ECG are normal. Which of the following is the most likely cause of her dyspnea?",
      "options": [
        {
          "label": "A",
          "text": "Heart failure",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stent thrombosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ticagrelor side effect",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ventricular septal rupture",
          "correct": false
        }
      ],
      "correct_answer": "C. Ticagrelor side effect",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Heart failure : Unlikely given the normal physical exam and imaging findings.</li><li>\u2022 Option A. Heart failure</li><li>\u2022 Option B. Stent thrombosis : Usually presents with acute coronary syndrome symptoms and ECG changes.</li><li>\u2022 Option B. Stent thrombosis</li><li>\u2022 Option D. Ventricular septal rupture : Rare complication of MI, usually presents with shock and a new murmur.</li><li>\u2022 Option D. Ventricular septal rupture</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Dyspnea is a well-recognized and often self-limited side effect of ticagrelor therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c305f11",
      "audio": ""
    },
    {
      "text": "Mr. Thiru is admitted after an anterior MI. In the ICU, he has frequent premature ventricular contractions (PVCs) and lab results show S. K of 2.9 mEq/L and S. Mg of 1 mg/dL. Which of the following is NOT indicated in this setting?",
      "options": [
        {
          "label": "A",
          "text": "IV lidocaine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Magnesium repletion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metoprolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Potassium repletion",
          "correct": false
        }
      ],
      "correct_answer": "A. IV lidocaine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Magnesium repletion : Indicated to correct hypomagnesemia, which can trigger arrhythmias.</li><li>\u2022 Option B. Magnesium repletion</li><li>\u2022 Option C. Metoprolol : Beta-blocker, reduces myocardial oxygen demand and helps prevent arrhythmias.</li><li>\u2022 Option C. Metoprolol</li><li>\u2022 Option D. Potassium repletion : Indicated to correct hypokalemia, which can also trigger arrhythmias.</li><li>\u2022 Option D. Potassium repletion</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Beta-blockers and correction of electrolyte imbalances re essential in preventing arrhythmias and reducing mortality in acute MI.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "db2620e3",
      "audio": ""
    },
    {
      "text": "Which of the following medications should be avoided in patients with an acute ST-elevation myocardial infarction?",
      "options": [
        {
          "label": "A",
          "text": "Aspirin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Colchicine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glucocorticoids",
          "correct": true
        },
        {
          "label": "D",
          "text": "Metoprolol",
          "correct": false
        }
      ],
      "correct_answer": "C. Glucocorticoids",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Aspirin: Aspirin is an antiplatelet medication that is beneficial in STEMI. It helps prevent further clot formation and reduces the risk of complications.</li><li>\u2022 Option A. Aspirin:</li><li>\u2022 Option B. Colchicine: Colchicine is an anti-inflammatory medication that can be used in certain cases of pericarditis, but it is not contraindicated in STEMI.</li><li>\u2022 Option B. Colchicine:</li><li>\u2022 Option D. Metoprolol: Metoprolol is a beta-blocker that reduces heart rate and blood pressure, decreasing the workload on the heart. It is beneficial in STEMI unless there are specific contraindications.</li><li>\u2022 Option D. Metoprolol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 NSAIDs (except aspirin) and glucocorticoids are absolutely C/I in STEMI.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4466751",
      "audio": ""
    },
    {
      "text": "Mrs. Hinduja, a 64-year-old woman, had a drug-eluting (everolimus) stent placed one month ago for a recent MI. She is on dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. Her ophthalmologist wants to know if these can be stopped for a cataract surgery next week. What is the most appropriate advice?",
      "options": [
        {
          "label": "A",
          "text": "Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discontinue both aspirin and clopidogrel and proceed with cataract surgery.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Postpone the surgery for 6 months.",
          "correct": true
        }
      ],
      "correct_answer": "D. Postpone the surgery for 6 months.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery, Option B. Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery and Option C. Discontinue both aspirin and clopidogrel and proceed with cataract surgery : Stopping either or both antiplatelet medications prematurely increases the risk of stent thrombosis and is not recommended.</li><li>\u2022 Option A. Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery, Option B. Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery</li><li>\u2022 Option C. Discontinue both aspirin and clopidogrel and proceed with cataract surgery</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Stopping DES in the first 6 months is associated with increased risk of in-stent thrombosis and hence, elective surgeries must be postponed.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "66661b23",
      "audio": ""
    },
    {
      "text": "A 67-year-old woman with stable heart failure with reduced ejection fraction (HFrEF) is on maximum doses of lisinopril, among other medications. Which treatment is most appropriate to further reduce HF hospitalizations and mortality?",
      "options": [
        {
          "label": "A",
          "text": "Add digoxin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Add ivabradine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase carvedilol dosage",
          "correct": false
        },
        {
          "label": "D",
          "text": "Switch lisinopril to valsartan-sacubitril",
          "correct": true
        }
      ],
      "correct_answer": "D. Switch lisinopril to valsartan-sacubitril",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Digoxin: While it can reduce HF hospitalizations, it does not improve mortality.</li><li>\u2022 Option A. Digoxin:</li><li>\u2022 Option B. Ivabradine: Used for patients with HFrEF in sinus rhythm and a high heart rate despite beta-blocker therapy. Not applicable here.</li><li>\u2022 Option B. Ivabradine:</li><li>\u2022 Option C. Increasing carvedilol: Might not be tolerated well and has not shown the same mortality benefit as valsartan-sacubitril.</li><li>\u2022 Option C. Increasing carvedilol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Valsartan-sacubitril significantly reduces heart failure hospitalizations and mortality in patients with symptomatic heart failure with reduced ejection fraction and is recommended in preference to an ACE inhibitor or angiotensin receptor blocker.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "33f5107d",
      "audio": ""
    },
    {
      "text": "An 18-year-old athlete experiences cardiac arrest during a race and is successfully resuscitated. Resting ECG is shown. Echocardiogram shows normal LV function but RV dilation and dysfunction. What is the most appropriate management before discharge?",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Genetic testing",
          "correct": false
        },
        {
          "label": "C",
          "text": "Implantable cardioverter-defibrillator (ICD)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lisinopril",
          "correct": false
        }
      ],
      "correct_answer": "C. Implantable cardioverter-defibrillator (ICD)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-115610.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Amiodarone: Antiarrhythmic medication, but not as effective as ICD for preventing sudden death.</li><li>\u2022 Option A. Amiodarone:</li><li>\u2022 Option B. Genetic testing: Important for diagnosis and family screening, but not the immediate priority before discharge.</li><li>\u2022 Option B. Genetic testing:</li><li>\u2022 Option D. Lisinopril: ACE inhibitor for LV dysfunction, not indicated in this case with normal LV function.</li><li>\u2022 Option D. Lisinopril:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Patients with sustained ventricular arrhythmias (>30 seconds) or cardiac arrest without a reversible cause have a class 1 recommendation for secondary prevention with implantable cardioverter-defibrillator placement.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8a93e8b3",
      "audio": ""
    },
    {
      "text": "A 70-year-old man presents with ascites, pedal edema and elevated JVP. ECG showed low voltage complexes and echo showed increased LV wall thickness. He also has a history of carpal tunnel syndrome. What is the most appropriate test?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac MRI",
          "correct": true
        },
        {
          "label": "B",
          "text": "Exercise echocardiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Right and left heart catheterization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serum \u03b1-galactosidase level",
          "correct": false
        }
      ],
      "correct_answer": "A. Cardiac MRI",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Exercise echocardiography: Primarily used to diagnose coronary artery disease.</li><li>\u2022 Option B. Exercise echocardiography:</li><li>\u2022 Option C. Right and left heart catheterization: Invasive and not the first-line test for infiltrative cardiomyopathy.</li><li>\u2022 Option C. Right and left heart catheterization:</li><li>\u2022 Option D. Serum \u03b1-galactosidase level: Used to diagnose Fabry disease, which usually causes Hypertrophic Cardiomyopathy.</li><li>\u2022 Option D. Serum \u03b1-galactosidase level:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cardiac magnetic resonance imaging with gadolinium is highly sensitive and specific for cardiac amyloidosis, but it does not distinguish between AL (immunoglobulin light-chain) amyloidosis and transthyretin amyloidosis.</li><li>\u27a4 In patients with cardiac magnetic resonance imaging findings consistent with cardiac amyloidosis, an abnormal 99m-technetium pyrophosphate scan would confirm transthyretin amyloidosis without the need for a biopsy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94f9825f",
      "audio": ""
    },
    {
      "text": "An 8-day postpartum woman presents with acute heart failure symptoms. Echocardiogram shows LV dilation and hypokinesis with an ejection fraction of 38%.RV is normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute pulmonary embolism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ascending aortic dissection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peripartum cardiomyopathy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Spontaneous coronary artery dissection",
          "correct": false
        }
      ],
      "correct_answer": "C. Peripartum cardiomyopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Acute pulmonary embolism : Less likely given normal right heart function on echocardiogram.</li><li>\u2022 Option A. Acute pulmonary embolism</li><li>\u2022 Option B. Ascending aortic dissection: Usually presents with acute chest pain, and echo would show aortic abnormalities.</li><li>\u2022 Option</li><li>\u2022 B. Ascending aortic dissection:</li><li>\u2022 Option D. Spontaneous coronary artery dissection: Typically presents with chest pain and ECG changes indicative of ischemia.</li><li>\u2022 Option</li><li>\u2022 D. Spontaneous coronary artery dissection:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Peripartum cardiomyopathy is left ventricular systolic dysfunction with onset toward the end of pregnancy or in the months after delivery in the absence of another identifiable cause; patients often present with features of heart failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d708d918",
      "audio": ""
    }
  ]
}